Buy new:
$19.59$19.59
FREE delivery: Friday, Jan 20 on orders over $25.00 shipped by Amazon.
Ships from: Amazon.com Sold by: Amazon.com
Buy used: $17.49
Other Sellers on Amazon
+ $4.97 shipping
93% positive over last 12 months
FREE Shipping
100% positive over last 12 months
+ $3.99 shipping
100% positive over last 12 months
Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet, or computer - no Kindle device required. Learn more
Read instantly on your browser with Kindle for Web.
Using your mobile phone camera - scan the code below and download the Kindle app.
Follow the Authors
OK
Estrogen Matters: Why Taking Hormones in Menopause Can Improve Women's Well-Being and Lengthen Their Lives -- Without Raising the Risk of Breast Cancer Hardcover – September 4, 2018
| Avrum Bluming (Author) Find all the books, read about the author, and more. See search results for this author |
| Carol Tavris (Author) Find all the books, read about the author, and more. See search results for this author |
| Price | New from | Used from |
|
Audible Audiobook, Unabridged
"Please retry" |
$0.00
| Free with your Audible trial | |
|
Audio CD, Audiobook, CD, Unabridged
"Please retry" | $22.40 | $28.60 |
Explore your book, then jump right back to where you left off with Page Flip.
View high quality images that let you zoom in to take a closer look.
Enjoy features only possible in digital – start reading right away, carry your library with you, adjust the font, create shareable notes and highlights, and more.
Discover additional details about the events, people, and places in your book, with Wikipedia integration.
Enhance your purchase
For years, hormone replacement therapy (HRT) was hailed as a miracle. Study after study showed that HRT, if initiated at the onset of menopause, could ease symptoms ranging from hot flashes to memory loss; reduce the risk of heart disease, Alzheimer's, osteoporosis, and some cancers; and even extend a woman's overall life expectancy. But when a large study by the Women's Health Initiative announced results showing an uptick in breast cancer among women taking HRT, the winds shifted abruptly, and HRT, officially deemed a carcinogen, was abandoned.
Now, sixteen years after HRT was left for dead, Dr. Bluming, a medical oncologist, and Dr. Tavris, a social psychologist, track its strange history and present a compelling case for its resurrection. They investigate what led the public -- and much of the medical establishment -- to accept the Women's Health Initiative's often exaggerated claims, while also providing a fuller picture of the science that supports HRT.
A sobering and revelatory read, Estrogen Matters sets the record straight on this beneficial treatment and provides an empowering path to wellness for women everywhere.
- Print length320 pages
- LanguageEnglish
- PublisherLittle, Brown Spark
- Publication dateSeptember 4, 2018
- Dimensions5.75 x 1 x 8.63 inches
- ISBN-100275952916
- ISBN-13978-0316481205
The Amazon Book Review
Book recommendations, author interviews, editors' picks, and more. Read it now
Customers who viewed this item also viewed
Editorial Reviews
Review
"Given breast cancer's substantial morbidity, mortality, emotional toll and the vast consequences of its treatment, the frontal salvo on the conventional wisdom of estrogen use by Avrum Bluming and Carol Tavris is refreshing and welcome. The book will stir a lively debate about the merits of decades of existing clinical research on estrogens and help reframe the way clinicians and patients view the tradeoff between the benefits and risks of hormone therapy."―Jerome P. Kassirer, MD, Distinguished Professor, Tufts University School of Medicine; Editor-in-Chief, New England Journal of Medicine
"This is such an important book, I want to do all I can to encourage every woman to read it. Groundbreaking and carefully researched, Estrogen Matters provides essential information about the many benefits of estrogen at menopause and even after a diagnosis of breast cancer. It reveals the misinterpretation of study results that led women (and their doctors) to have unwarranted concerns about estrogen use. The thoughtful information presented here will help women feel more comfortable taking estrogen, leading to healthier, longer lives for many."―Patricia T. Kelly, PhD, specialist in cancer risk assessment and author of Assessing Your True Risk of Breast Cancer
"This book is long overdue, and I salute the authors for their courage and effort (and their clear, witty writing). I believe it is an ethical imperative for all clinicians who treat women in menopause or women with breast cancer to alert their patients to this book. It will not only improve women's quality of life, but also, on balance of probabilities, extend women's lives by delaying death from all other causes."―Michael Baum, MD, professor emeritus of surgery and visiting professor of medical humanities, University College London
"Once considered a veritable fountain of youth, estrogen replacement got a bad rap with the Women's Health Initiative study. This book is an exhaustively researched and meticulously reasoned vindication of hormone replacement therapy. Estrogen matters: it's the most effective treatment for hot flashes and other symptoms of menopause, and when started early and used continuously, it has important health benefits and can actually prevent some of the adverse events it was thought to cause. Bluming and Tavris tell estrogen's story in a way that is both accessible to the general public and appropriate for professionals. What's more, they provide valuable insights into understanding research and how even the best randomized controlled studies can lead to unjustified public fears and injudicious clinical recommendations. Very enlightening!"―Harriet Hall, editor, Science-Based Medicine
"Well written, insightful, and hard hitting, Estrogen Matters successfully rebuts the billion-dollar, government-led study known as the Women's Health Initiative, which claimed that hormones for post-menopausal women are harmful. That study was wrong. It turns out estrogens do matter for women's health."―Vincent T. DeVita Jr., MD, Professor of Medicine, Yale School of Public Health and Yale Cancer Center
"This book is long overdue. Having spent over two decades advancing women's health, I was appalled by the Women's Health Initiative's efforts to sensationalize and distort their own findings to promote an anti-hormone-therapy agenda. Personally I have been taking HRT for over 25 years and have no intention of stopping. I hope Estrogen Matters draws enough attention to counter the fears and misinformation about HRT that so many women, and their physicians, still hold."―Phyllis Greenberger, MSW, former President and CEO of the Society for Women's Health Research
"If you're one of the many menopausal women who reflexively avoid hormone replacement therapy to treat your symptoms because of all the scary headlines, this book is a must-read. The authors deftly cut through the hype to build a strong, well-reasoned case for challenging the current accepted wisdom."―Jennifer Ouellette, author of Me, Myself and Why and The Calculus Diaries
"For far too many years women and their doctors have been held in fear of prescribing estrogens -- believing that they were dangerous because of a widely quoted study purporting to show that they were too damaging. Now it turns out that this seems to have been an example of 'fake' news. In a thorough, careful, and unbiased assessment of all the scientific evidence, Bluming and Tavris debunk this most widely quoted work and show that estrogens are not only not dangerous but beneficial for the vast majority of women suffering from post-menopausal symptoms, whether or not they have had breast cancer. This extremely valuable message deserves to be widely disseminated."―Lord Turnberg, former President of the Royal College of Physicians
About the Author
Carol Tavris, PhD, is a social psychologist who has written widely about psychological science. Her trade books include Anger; The Mismeasure of Woman; and, with Elliot Aronson, Mistakes Were Made (But Not by Me). She has won numerous awards for her science writing and contributions to skepticism and gender equity.
Product details
- ASIN : 0316481203
- Publisher : Little, Brown Spark; 1st edition (September 4, 2018)
- Language : English
- Hardcover : 320 pages
- ISBN-10 : 0275952916
- ISBN-13 : 978-0316481205
- Item Weight : 14.4 ounces
- Dimensions : 5.75 x 1 x 8.63 inches
- Best Sellers Rank: #15,921 in Books (See Top 100 in Books)
- #5 in Breast Cancer (Books)
- #8 in Menopause (Books)
- #72 in General Women's Health
- Customer Reviews:
About the authors

Carol Tavris is a social psychologist, writer, and lecturer whose goal is to promote psychological science and critical thinking in improving our lives. She is coauthor, with Elliot Aronson, of "Mistakes Were Made (But Not by ME): Why we justify foolish beliefs, bad decisions, and hurtful acts" (third edition, 2020) and, with Avrum Bluming, "Estrogen Matters: Why taking hormones in menopause can improve women's well-being and lengthen their lives--without raising the risk of breast cancer." Her other major books include the landmark "Anger: The misunderstood emotion," a book well known for its critical look at unvalidated notions about the inevitability of anger and the need to "ventilate" it, and how anger can best be expressed constructively. She is also author of the award-winning "The Mismeasure of Woman: Why women are not the better sex, the inferior sex, or the opposite sex." She has written hundreds of essays and book reviews on topics in psychological science, writes a column ("The Gadfly") for Skeptic magazine, and is a highly regarded lecturer who has spoken to groups around the world. She is a Fellow of the Association for Psychological Science and the Los Angeles Institute for the Humanities.

Avrum Bluming received his Bachelor of Arts degree from Columbia College, where he majored in music, and his M.D. degree from the Columbia College of Physicians and Surgeons where he was elected to the academic honor society, Alpha Omega Alpha.
He spent 4 years as a Senior Investigator for the National Cancer Institute and, for two of those years, was Director of the Lymphoma Treatment Center in Kampala, Uganda, where he was also an Honorary Lecturer at Makerere University.
He has taught at medical and academic institutions around the country, including Harvard, Princeton, Johns Hopkins and Columbia Universities, as well as UCLA and USC. He is an Emeritus Clinical Professor of Medicine at USC, and has been an invited speaker at the Royal College of Physicians in London, the Pasteur Institute in Paris, and the International Society of Hematology in Jerusalem.
He has served as Director of Oncology, Chief of Medicine and Chief of Staff at both Encino Hospital and at the Tarzana Regional Medical Center, now called the Providence Tarzana Medical Center, where he was Director of Continuing Medical Education for four years. He has been a practicing medical oncologist in Encino since 1975.
In 1994, he was elected to Mastership in the American College of Physicians, an honor accorded to only 500 of the over 100,000 Board-certified Internists in this country. Since 1994, he has been consistently listed in the Woodward-White book, The Best Doctors in America.
In the 1970’s he was a fellow panelist with Lewis Thomas at Johns Hopkins University at an NCI sponsored conference on Spontaneous Regression of Cancer (Bluming AZ: Spontaneous regression of sarcoma. Nat Cancer Inst Monogr 1976;44:55-57.)
In 1998, he was a speaker at the 9th Roundtable of the Council for Technology and the Individual (CTI). Other speakers at that program included: Jeff Bezos, Stewart Brand, Leonard Kleinrock, Alan Kay, Ray Kurzweil, Paul MacCready, Steven McGeady, Walt Mossberg, Paul Saffo, John Scully, and Rick Smolan.
He has been a reviewer for many medical journals including: Blood, Cancer Research, Johns Hopkins Medical Journal, Journal of Clinical Investigation, Journal of Clinical Oncology, Journal of the American Medical Association, Journal of the National Cancer Institute, New England Journal of Medicine, and Science.
He has been profiled in the Los Angeles Times and the British medical publication, The Lancet. He has been quoted in the New York Times, Newsweek, Scientific American, and the Wall Street Journal. He is mentioned in Norman Cousin’s book, Head First - The Biology of Hope, in Jack Canfield’s book, Chicken Soup for the Surviving Soul, in Gail Sheehy’s book, The Silent Passage, and in Berry Gordy’s book, To Be Loved.
He has cooked with Danny Kaye, played Balalaika - guitar duets with Theodore Bikel, jogged with Frank Shorter, long distance running Olympic medalist, performed in front a medical audience with Patch Adams, was introduced by Gregory Peck at an LA Free-Net kickoff fundraiser event, flew a T33 jet fighter, flew over the Taklamakan Desert in an ultralite, traveled with the Tuareg in the Southern Sahara, spent time in a Buddhist Monastery on Mount Koya in Japan, and was the official Mohel for the Jewish community in Uganda, where, for a very brief time, he was also physician to Idi Amin.
He is a founder and was President for over 20 years of the H.O.P.E. Foundation, established to provide both information and bereavement counseling to families touched by cancer, and is a founder and first President of the Los Angeles Free-Net, a non-profit organization, inaugurated in 1994, providing inexpensive internet access (free to K-12 students) and extensive medical information resources on the World Wide Web. In 1996, the Clinton White House identified the Los Angeles Free-Net as the prototype for community information resources that should be emulated around the country.
He organized the first study of lumpectomy for the treatment of breast cancer in Southern California in 1978; he was a co-investigator on the original study evaluating the relationship between the timing of initial breast cancer surgery within the menstrual cycle and prognosis, and for the past 22 years, he has been studying and publishing the benefits and risks of hormone replacement therapy administered to women with a previous history of treated breast cancer.
His most Publication, written with Dr. Carol Tavris, a Social Psychologist and author, is entitled:
Estrogen Matters: Why taking hormones in menopause can improve women’s well-being and lengthen their lives - without raising the risk of breast cancer.
Customer reviews
Customer Reviews, including Product Star Ratings help customers to learn more about the product and decide whether it is the right product for them.
To calculate the overall star rating and percentage breakdown by star, we don’t use a simple average. Instead, our system considers things like how recent a review is and if the reviewer bought the item on Amazon. It also analyzed reviews to verify trustworthiness.
Learn more how customers reviews work on Amazon-
Top reviews
Top reviews from the United States
There was a problem filtering reviews right now. Please try again later.
The authors answer many questions that women face: What is the relationship between HRT and heart disease and bone fractures/osteoporosis? (It significantly reduces the risk of both.) Does estrogen cause breast cancer? (No.) What does science say about HRT and cognitive function? (It is the one thing that helps women in their later years.) Can women who have had breast cancer take HRT to reduce symptoms of menopause and achieve better health and quality of life? (Yes.)
The authors recount the untold story of the Women’s Health Initiative (WHI), which profoundly changed the way physicians think about HRT and frightened millions of women from taking it; their fascinating and shocking account reveals the WHI’s shortcomings, exaggerated fear-generating “findings,” and statistical deceptions—and the WHI’s own unwillingness to report any good news about HRT.
“In short, I can’t recommend this engaging book more highly — for women in the years before and during menopause, for doctors, and for anyone interested in science and medicine.”
Allopathic practioners NEED to read this book before not prescribing hormone replacement for those of us who are at a stage of declining hormones.












